See today's BioWorld
To read the full story, subscribe or sign in.

PDUFA VII keeping pace with the present, prepping for the future

Sep. 28, 2021
By Mari Serebrov
The PDUFA commitment letter negotiated between industry and the U.S FDA every five years provides an inside look at the future of drug development. The PDUFA VII letter, which is to be presented to Congress by Jan. 15, is no exception.
BioWorld Drugs Regulatory Cell therapy Gene therapy FDA PDUFA